Oklahoma City, OK, United States of America

Mohan Purushothaman

This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignees: Oklahoma Medical Research Foundation, Progentec Diagnostics, Inc.. Active years: 2022-2025.

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 2.7

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Mohan Purushothaman: Innovator in Autoimmune Disease Management

Introduction

Mohan Purushothaman is a notable inventor based in Oklahoma City, OK (US). He has made significant contributions to the field of autoimmune disease management, holding 2 patents that focus on innovative methods for diagnosing and managing conditions such as systemic lupus erythematosus (SLE).

Latest Patents

His latest patents include a method for characterizing disease activity in SLE patients. This method involves obtaining a dataset from a blood, serum, plasma, or urine sample and assessing various biomarkers to calculate a Lupus Disease Activity Immune Index (LDAII) score. Additionally, he has developed an artificial intelligence (AI) system designed to manage autoimmune conditions. This system utilizes machine learning to monitor patients and alert clinicians to potential symptom flares, providing treatment solutions to mitigate severity.

Career Highlights

Mohan has worked with several prominent organizations, including Progentec Diagnostics, Inc. and the Oklahoma Medical Research Foundation. His work has been instrumental in advancing the understanding and management of autoimmune diseases.

Collaborations

Throughout his career, Mohan has collaborated with esteemed colleagues such as Judith Ann James and Eldon R Jupe. These partnerships have further enriched his research and innovations in the field.

Conclusion

Mohan Purushothaman's contributions to autoimmune disease management through his patents and collaborations highlight his commitment to improving patient care. His innovative approaches are paving the way for advancements in the diagnosis and treatment of complex autoimmune conditions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…